Dixon Hubard Feinour & Brown Inc Merck & Co., Inc. Transaction History

Dixon Hubard Feinour & Brown Inc

$842 Million
Q2 2022

A detailed history of Dixon Hubard Feinour & Brown Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Dixon Hubard Feinour & Brown Inc holds 76,828 shares of MRK stock, worth $9.97 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares

76,828

Previous 73,765 4.15%

Holding current value

$9.97 Million

Previous $6.05 Million 15.73%

% of portfolio

0.83%

Previous 0.61%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$83.49 - $94.64 $255,729 - $289,882	3,063 Added 4.15%	76,828 $7 Million
Q1 2022 May 09, 2022	BUY	$73.51 - $82.4 $45,870 - $51,417	624 Added 0.85%	73,765 $6.05 Million
Q4 2021 Jan 10, 2022	BUY	$72.28 - $90.54 $4.02 Million - $5.04 Million	55,650 Added 318.16%	73,141 $5.61 Million
Q3 2021 Oct 19, 2021	SELL	$71.68 - $78.83 $124,221 - $136,612	-1,733 Reduced 9.01%	17,491 $1.31 Million
Q2 2021 Aug 23, 2021	SELL	$70.31 - $77.77 $169,798 - $187,814	-2,415 Reduced 11.16%	19,224 $1.5 Million

Q1 2021 May 14, 2021	SELL	$68.86 - $81.11 $437,536 - $515,372	-6,354 Reduced 22.7%	21,639 $1.67 Million
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $22,685 - $25,714	-310 Reduced 1.1%	27,993 $2.32 Million
Q2 2020 Jul 31, 2020	SELL	$70.42 - $80.13 $33,801 - $38,462	-480 Reduced 1.67%	28,303 $2.26 Million
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $362,989 - $503,120	5,729 Added 24.85%	28,783 $2.22 Million
Q3 2019 Nov 13, 2019	SELL	$76.08 - $82.93 $8,673 - $9,454	-114 Reduced 0.49%	23,054 $1.94 Million
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $36,316 - $42,426	520 Added 2.3%	23,168 $1.94 Million
Q1 2019 May 17, 2019	BUY	$69.58 - $79.36 $134,428 - $153,323	1,932 Added 9.33%	22,648 $1.88 Million
Q4 2018 Feb 13, 2019	SELL	$65.24 - $75.71 $10,960 - $12,719	-168 Reduced 0.8%	20,716 $1.58 Million
Q2 2018 Jul 25, 2018	SELL	$50.83 - $59.72 $102,168 - $120,037	-2,010 Reduced 8.78%	20,884 $1.27 Million
Q1 2018 May 14, 2018	SELL	$50.96 - $59.23 $70,987 - $82,507	-1,393 Reduced 5.74%	22,894 $1.25 Million
Q4 2017 Feb 20, 2018	BUY	$51.62 - $61.64 $88,012 - $105,096	1,705 Added 7.55%	24,287 $1.37 Million
Q3 2017 Nov 08, 2017	BUY	$58.67 - $63.13 $1.32 Million - $1.43 Million	22,582	22,582 $1.45 Million

Others Institutions Holding MRK

# of Institutions

3,765

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $329B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dixon Hubard Feinour & Brown Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dixon Hubard Feinour & Brown Inc with notifications on news.

Account

Dixon Hubard Feinour & Brown Inc Merck & Co., Inc. Transaction History